New York, NY, United States of America

Eric Gouaux

This inventor holds 1 USPTO granted patent. Top assignee: University of Massachusetts. Active years: 2004.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 127(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Eric Gouaux

Introduction

Eric Gouaux is a prominent inventor based in New York, NY (US). He is known for his groundbreaking work in the field of biosensors. His innovative approach to designing protein pores has significant implications for the detection and quantification of various analytes.

Latest Patents

Eric Gouaux holds a patent for a mutant staphylococcal alpha hemolysin polypeptide. This polypeptide contains a heterologous analyte-binding amino acid, which assembles into an analyte-responsive heptameric pore assembly in the presence of a wild type staphylococcal alpha hemolysin polypeptide. His work focuses on digital biosensors and methods for detecting, identifying, and quantifying analytes. He has 1 patent to his name.

Career Highlights

Eric Gouaux is affiliated with the University of Massachusetts, where he continues to contribute to the field of biosensor technology. His research has paved the way for advancements in the detection of various biological and chemical substances.

Collaborations

Some of his notable coworkers include Hagan Bayley and Orit Braha. Their collaborative efforts have further enhanced the research and development of innovative biosensing technologies.

Conclusion

Eric Gouaux's contributions to the field of biosensors exemplify the impact of innovative thinking in scientific research. His work continues to influence advancements in the detection and quantification of analytes, showcasing the importance of collaboration and creativity in the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…